Skandinaviska Enskilda Banken (SEB)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Sell |
82,750
-166,200
| -67% | -$9.19M | 0.02% | 439 |
|
|
2025
Q1 | $12M | Sell |
248,950
-61,700
| -20% | -$2.98M | 0.06% | 247 |
|
|
2024
Q4 | $12M | Buy |
310,650
+80,536
| +35% | +$3.1M | 0.05% | 247 |
|
|
2024
Q3 | $10.4M | Buy |
230,114
+211,200
| +1,117% | +$9.5M | 0.05% | 270 |
|
|
2024
Q2 | $655K | Hold |
18,914
| – | – | ﹤0.01% | 671 |
|
|
2024
Q1 | $547K | Hold |
18,914
| – | – | ﹤0.01% | 703 |
|
|
2023
Q4 | $434K | Hold |
18,914
| – | – | ﹤0.01% | 786 |
|
|
2023
Q3 | $315K | Hold |
18,914
| – | – | ﹤0.01% | 802 |
|
|
2023
Q2 | $522K | Buy |
+18,914
| New | +$522K | ﹤0.01% | 786 |
|
|
2022
Q4 | – | Sell |
-48,977
| Closed | -$413K | – | 898 |
|
|
2022
Q3 | $413K | Hold |
48,977
| – | – | ﹤0.01% | 767 |
|
|
2022
Q2 | $387K | Hold |
48,977
| – | – | ﹤0.01% | 839 |
|
|
2022
Q1 | $1.16M | Buy |
48,977
+10,673
| +28% | +$253K | 0.01% | 739 |
|
|
2021
Q4 | $1.31M | Hold |
38,304
| – | – | 0.01% | 733 |
|
|
2021
Q3 | $679K | Buy |
38,304
+7,676
| +25% | +$136K | ﹤0.01% | 840 |
|
|
2021
Q2 | $1.38M | Buy |
+30,628
| New | +$1.38M | 0.01% | 757 |
|